Not checked for notices yet.
CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast Cancer
Yuan-ke Liang, Yuan-ke Liang, Ze-kun- Deng and 14 more
Frontiers in Oncology · 2021
Cited by papers we hold 1
- Biomarkers of response to PD-1 pathway blockade · 2022No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.